| Juan J Sanchez Ramirez, MD | |
|
200 Hawkins Dr, Iowa City, IA 52242-1009 | |
| (319) 335-3500 | |
| Not Available |
| Full Name | Juan J Sanchez Ramirez |
|---|---|
| Gender | Male |
| Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
| Location | 200 Hawkins Dr, Iowa City, Iowa |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1871210401 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | R-12390 (Iowa) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Juan J Sanchez Ramirez, MD 1012 Newton Rd Apt 3, Iowa City, IA 52246-2225 Ph: (319) 855-9337 | Juan J Sanchez Ramirez, MD 200 Hawkins Dr, Iowa City, IA 52242-1009 Ph: (319) 335-3500 |
News Archive
The Association for Molecular Pathology (AMP), the premier global, non-profit organization serving molecular diagnostic professionals, submitted written comments on March 20 to the U.S. Food and Drug Administration (FDA) in response to the agency's request for feedback in association with its February 20, 2015 public workshop entitled, "Optimizing FDA's Regulatory Oversight of Next Generation Sequencing Diagnostic Tests."
An antibody loaded with an anti-cancer agent produced complete or partial remissions in 38 percent of patients with relapsed or therapy-resistant Hodgkin lymphoma enrolled in a phase I clinical trial, investigators report in the Nov. 4 issue of the New England Journal of Medicine.
Millions of Americans are progressively losing their sight as cells in their eyes deteriorate, but a new therapy developed by researchers at the University of California, Berkeley, could help prolong useful vision and delay total blindness.
Dasatinib, an experimental drug under development by Bristol-Myers Squibb, reverses the signs and symptoms of patients whose chronic myeloid leukemia has failed to respond to Gleevec, which is considered the standard of treatment for the disorder.
› Verified 2 days ago
Dr. John Phillip Lee, D.O. Pathology Medicare: Accepting Medicare Assignments Practice Location: 200 Hawkins Dr, Dept Of Pathology, Iowa City, IA 52242 Phone: 319-384-9605 Fax: 319-467-5193 | |
Dr. Carol Joy Holman, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 200 Hawkins Dr, Iowa City, IA 52242 Phone: 319-356-3981 Fax: 319-384-8051 | |
James A Goeken, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 200 Hawkins Dr, Iowa City, IA 52242 Phone: 319-356-1966 Fax: 319-384-8053 | |
Sergei I Syrbu, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 200 Hawkins Dr, Iowa City, IA 52242 Phone: 319-356-7372 Fax: 319-384-8053 | |
Jo A Benda, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 200 Hawkins Dr, Iowa City, IA 52242 Phone: 319-356-4436 Fax: 319-384-8052 | |
Amani Abdalla Bashir, MBBS Pathology Medicare: Accepting Medicare Assignments Practice Location: 200 Hawkins Drive, University Of Iowa Hospitals And Clinics, Iowa City, IA 52242 Phone: 319-467-5706 Fax: 319-356-8470 | |
Mr. Paul J Belding, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 321 E Market St Ste 102, Iowa City, IA 52245 Phone: 319-337-7284 Fax: 319-337-7284 |